British journal of rheumatology最新文献_第3页

A study of the frequency of pericardial and pleural effusions in scleroderma. 硬皮病患者心包积液和胸腔积液频率的研究。

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1320

A E Thompson, J E Pope

{"title":"A study of the frequency of pericardial and pleural effusions in scleroderma.","authors":"A E Thompson, J E Pope","doi":"10.1093/rheumatology/37.12.1320","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1320","url":null,"abstract":"Objective: To determine the frequency of pericardial and pleural effusions in scleroderma.Methods: Using a case-control format, patients with scleroderma and no known cardiac disease were recruited. Echocardiograms and chest radiographs were performed. Age- and gender-matched controls had echocardiograms performed which were read by a cardiologist, blinded to the diagnosis. The medical records of 60 other scleroderma patients were also reviewed.Results: Thirty-seven scleroderma subjects were recruited, of whom 18 had diffuse disease. Only eight subjects with diffuse disease and five with limited scleroderma had normal echocardiograms compared to 20 of 37 controls (P < 0.1). Two had pericardial effusions, both with diffuse scleroderma, and none of the controls had effusions present. Pulmonary hypertension occurred in three with diffuse disease and no controls. A chart review of a further 60 patients with scleroderma was performed. Pleural effusions were identified in 7% (4/58) of the cohort of scleroderma patients and were more frequent in diffuse disease (10%). A total of 17% (4/23) of diffuse and 4% (1/23) of limited scleroderma patients had evidence of pericardial effusions.Conclusions: Pericardial effusions do occur in scleroderma without evidence of clinical cardiac dysfunction and are more common in diffuse scleroderma. Pleural effusions in scleroderma occur less frequently, in 70%.","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1320-3"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1320","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 72

Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. 6个月长期体能训练对多发性肌炎/皮肌炎患者的益处

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1338

G F Wiesinger, M Quittan, M Graninger, A Seeber, G Ebenbichler, B Sturm, K Kerschan, J Smolen, W Graninger

{"title":"Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.","authors":"G F Wiesinger, M Quittan, M Graninger, A Seeber, G Ebenbichler, B Sturm, K Kerschan, J Smolen, W Graninger","doi":"10.1093/rheumatology/37.12.1338","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1338","url":null,"abstract":"Objective: The benefit of long-term physical training in patients with chronic polymyositis or dermatomyositis (PM/DM) was studied prospectively.Methods: Eight patients with chronic PM/DM participated in a training programme for 6 months. A group of five PM/DM patients without any physical training was observed for control purposes.Results: While there was no significant change in serum creatine phosphokinase (CPK) levels, the 'activities of daily living (ADL)' score improved significantly (P < 0.03), peak isometric torque (PIT) generated by muscle groups in the lower extremities rose significantly (P < 0.03) and there was a statistically highly significant increase in peak oxygen uptake (VO2max) relative to body weight (P < 0.02) due to the long-term training. The patients improved their aerobic capacity by 28%, which is clinically significant. In the untrained patients, no improvement in these target parameters was observed.Conclusion: In clinically stable DM/PM patients, long-term physical training can safely be performed and is recommended as part of a comprehensive rehabilitation management, particularly in view of the cardiopulmonary risk in these patients.","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1338-42"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1338","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 112

Post-streptococcal reactive myalgia: a novel syndrome secondary to infection with group A or G streptococci. 链球菌感染后反应性肌痛:一种继发于a组或G组链球菌感染的新型综合征。

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1343

T L Jansen, M Janssen, J D Macfarlane, A J de Jong

引用次数: 15

Haemophagocytic syndrome in a patient with dermatomyositis. 皮肌炎患者的噬血细胞综合征。

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1357

S Yasuda, A Tsutsumi, T Nakabayashi, T Horita, K Ichikawa, M Ieko, T Koike

引用次数: 21

Sensorineural hearing loss, iritis and ankylosing spondylitis. 感音神经性听力损失，虹膜炎和强直性脊柱炎。

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1363

K Raza, D Karokis, F Wilson, J P Delamere

引用次数: 15

A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. 针对糖基化IgG的类风湿性关节炎新抗体:IgM抗IgG- age。

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1307

S Ligier, P R Fortin, M M Newkirk

{"title":"A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE.","authors":"S Ligier, P R Fortin, M M Newkirk","doi":"10.1093/rheumatology/37.12.1307","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1307","url":null,"abstract":"Hyperglycaemia and/or oxidative stress can cause IgG to be modified by advanced glycation end products (AGE). Three patients with aggressive rheumatoid arthritis (RA) and vasculitis are described who have high titres of IgM antibodies against AGE-modified IgG (IgM anti-IgG-AGE). Diabetics and randomly selected patients with rheumatic diseases, including 50 additional RA patients, were tested for IgM and IgA anti-IgG-AGE by ELISA. AGE-modified proteins were detected using the nitroblue tetrazolium (NBT) colorimetric method. The presence of Nepsilon (carboxymethyl) lysine, an AGE modification, was detected on IgG-AGE by immunoblotting. A total of 20/41 (49%) rheumatoid factor (RF)-positive RA patients tested had IgM anti-IgG-AGE antibodies, 4/12 (33%) RF-positive systemic lupus erythematosus (SLE) patients, 3/5 RF-positive patients with primary Sjogren's syndrome (SS), and 3/5 RF-positive diabetics. All patients with RF-negative RA, SLE, SS, osteoarthritis (24), spondyloarthritis (15), adult-onset Still's disease (8), diabetes (25) and healthy controls (20) were anti-IgG-AGE negative. RF and IgM anti-IgG-AGE appeared to be a linked response. The IgM anti-IgG-AGE, along with IgG-AGE, may contribute to the pathogenesis of RA.","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1307-14"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1307","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 65

Sternum tumour revealing a chronic myeloid leukaemia. 胸骨肿瘤显示慢性髓性白血病。

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1353

E Blot, J Miquel, F Heron, H Tilly, H Levesque, H Courtois

引用次数: 4

IgA class serum antibodies against three different Klebsiella serotypes in ankylosing spondylitis. 强直性脊柱炎中抗三种不同克雷伯氏菌血清型的IgA类血清抗体。

British journal of rheumatology Pub Date : 1998-12-01

O Mäki-Ikola, M Nissilä, K Lehtinen, K Granfors

引用次数: 0

Long-term outcomes of an arthritis self-management programme. 关节炎自我管理方案的长期结果。

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1315

J H Barlow, A P Turner, C C Wright

{"title":"Long-term outcomes of an arthritis self-management programme.","authors":"J H Barlow, A P Turner, C C Wright","doi":"10.1093/rheumatology/37.12.1315","DOIUrl":"https://doi.org/10.1093/rheumatology/37.12.1315","url":null,"abstract":"Objective: A previous UK evaluation of the Arthritis Self-Management Programme (ASMP) demonstrated 4 month improvements in physical and psychological well-being including increased arthritis self-efficacy and increased use of self-management behaviours such as cognitive symptom management, and reductions in pain, fatigue and anxiety. The purpose of this study was to determine whether these effects were maintained at 12 month follow-up.Methods: Twelve month data were collected via self-administered questionnaires mailed to participants who had previously responded prior to attending the ASMP and at 4 months follow-up.Results: The sample (n = 112) comprised 82% women with a mean age of 59.6 (S.D. 12.4) yr and a mean disease duration of 14.9 (S.D. 11.1) yr. The majority of participants had a general practitioner-recorded diagnosis of either rheumatoid arthritis (46%) or osteoarthritis (44%). Many of the changes noted at 4 months were sustained at the 12 month follow-up.Conclusion: This first long-term evaluation of a community-based patient education intervention delivered in the UK suggests that after participation in the ASMP, persons with arthritis derive substantial and prolonged benefits in terms of perceived ability to manage arthritis, reduction in pain and improved psychological well-being.","PeriodicalId":9307,"journal":{"name":"British journal of rheumatology","volume":"37 12","pages":"1315-9"},"PeriodicalIF":0.0,"publicationDate":"1998-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/rheumatology/37.12.1315","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40729217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 149

Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. 强直性脊柱炎患者肺炎克雷伯菌脂多糖抗体的研究。

British journal of rheumatology Pub Date : 1998-12-01 DOI: 10.1093/rheumatology/37.12.1330

K Ahmadi, C Wilson, H Tiwana, A Binder, A Ebringer

引用次数: 34